Calvin Klein, Tommy Hilfiger retailer Arvind Fashions’ Q3 profit rises by 58.20% to Rs 47.65 cr despite muted market conditions

Arvind Fashions, which retails international brands such as Arrow, Calvin Klein and Tommy Hilfiger in India, on Wednesday released its fiscal third quarter earnings with profit at Rs 47.65 crore, posting a growth of 58.20 per cent in comparison to Rs 30.12 crore during the same period of FY24. It reported Q3 revenue from operations at Rs 1,202.76 crore, up 6.91 per cent as against Rs 1,125.05 crore recorded during the third quarter of previous financial year. The company EBITDA was up 15 per cent YoY at Rs 165 crore. 

ALSO READInfo Edge board approves first-ever stock split in 1:5 ratio – Check record date and other details

The company said that robust growth was witnessed across retail & online B2C channel, while wholesale channel stayed flat. Retail LTL was strong at 11 per cent, led by investments in upgrading customer experience and differentiated celebrity capsule collections.

Shailesh Chaturvedi, MD & CEO, Arvind Fashions, said, “AFL delivered yet another quarter of differentiated results despite tepid demand scenario across the industry. Retail LTL of 11 per cent is a clear reflection of our conscious investments in upgrading customer experience and celebrity collab collection, helping deliver 7 per cent revenue growth. Favourable channel mix & lower discounting coupled with cost efficiencies resulted in the highest ever quarterly EBITDA and 71 per cent growth in PAT. Our decisive focus on scaling existing brands is helping us gain market share. Moving forward, we will continue to stay committed to profitable growth & generate higher ROCE.”

At the end of Q3FY25, Arvind Fashions said, the company recorded gross addition of 34 EBOs and net sqft stood at approximately 11.5L sqft. In FY25, the company is looking forward to gross opening of around 150 stores, largely through Franchise Owned Franchise Operated (FOFO) route, while also adding significant net sqft over FY24. 

 » Read More

Related Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

Rupee fall hurts India Inc hard

The rupee inched closer to the 88-mark against the US dollar on Monday, putting companies in import-sensitive sectors on the edge. While firms fear a surge in imported inflation on account of rupee depreciation, consumer electronics companies, for instance, are taking price hikes to protect margins. In sectors such as thermal power, where the cost

Bata India Q3 profit grows marginally to Rs 58.6 crore on weak demand

Footwear major Bata India on Monday reported a marginal 1% growth in its net profit at Rs 58.6 crore during the October-December quarter, as compared to Rs 57.9 crore in the same quarter in 2023-24. Bloomberg consensus estimates had pegged the net profit during the quarter at Rs 72 crore.  The company’s revenue from operations